TUESDAY, Feb. 23, 2021 (HealthDay News) — More Asian and Hispanic people with lupus die prematurely than white patients, a new study reveals. Death rates in San Francisco were nearly six times higher than expected among Hispanic patients with lupus and four times higher than expected among Asian women withContinue Reading

TUESDAY, Feb. 16, 2021 (HealthDay News) — Gene variants associated with a rare autoimmune disorder called Addison’s disease have been pinpointed, according to researchers. “By studying the single largest collection of samples from patients with Addison’s disease, we’ve been able to carry out the first genetic study of the diseaseContinue Reading

FRIDAY, Feb. 12, 2021 (HealthDay News) — Here’s some good news for people who’ve had solid organ transplants and have weakened immune systems: mRNA coronavirus vaccines are safe for these vulnerable folks, new research shows. The study included 187 transplant recipients who received an initial dose of either the ModernaContinue Reading

MONDAY, Feb. 8, 2021 (HealthDay News) — While scientists still don’t know what causes Parkinson’s disease, new research shows an association between a drug that some men take for an enlarged prostate condition and a reduced risk of developing the illness. A team led by scientists at the University ofContinue Reading

THURSDAY, Jan. 21, 2021 (HealthDay News) — Stem cell transplants may have long-lasting benefits for some people with aggressive cases of multiple sclerosis, a new study suggests. Italian researchers found that among 210 multiple sclerosis (MS) patients who received a stem cell transplant — with cells from their own bloodContinue Reading

MONDAY, Oct. 26, 2020 (HealthDay News) — When the new coronavirus pandemic first began, respiratory distress immediately became the hallmark of severe COVID-19 illness. News reports focused on the inability to breathe, low oxygen saturation levels and the alarming need for ventilators. But six months later, experts are becoming increasinglyContinue Reading

MONDAY, Oct. 19, 2020 (HealthDay News) — A recently approved rheumatoid arthritis medication appears to be an effective second-line therapy when biologic treatments start to fail, a new clinical trial reports. Arthritis sufferers treated with upadacitinib had a significantly greater reduction in their symptoms and disease activity than people treatedContinue Reading